MDxHealth's Q1 Revenues Plunge 47 Percent

The Belgian company attributed the sharp decline to a drop in grant revenues as the company moved away from basic research to molecular diagnostics development during the past year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories